Nephropathy
Not recruitingStudy on the Effects of Povetacicept for Adults with IgA Nephropathy
- Disease:Nephropathy
- Substances:Povetacicept
Denmark- Participants:18–64 years · 65+ years
- Substances:Povetacicept
- Sponsor:Alpine Immune Sciences Inc.
Rare diseases
Investigational molecules
Locations
Back to Denmark327 clinical trials in Aalborg, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Denmark
Denmark
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on endometrial cancer and metastatic prostate cancer treatments. Studies evaluating new therapeutic combinations and investigating cannabidiol's potential in cancer care.
Multiple trials exploring targeted therapies and quality of life improvements for cancer patients.
Comprehensive studies on meningococcal vaccines and chickenpox prevention in children. Research includes RSV prevention and inflammatory conditions.
Focus on preventive medicine and immune system responses in various age groups.
Investigations into inflammatory bowel diseases including studies on Crohn's Disease and Ulcerative Colitis. Research on opioid-induced bowel dysfunction.
Advancing understanding of digestive system disorders and their management.
Research on chronic kidney disease treatments and heart failure prevention. Studies examining new approaches for cardiovascular disease management.
Innovative approaches to managing complex cardio-renal conditions.
Studies investigating treatments for amyotrophic lateral sclerosis and dual diagnosis of schizophrenia with alcohol use disorder.
Exploring new therapeutic options for complex neurological and psychiatric conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.